Wake Up Call: Dorsey & Whitney Symposium to Feature Indicted Pharma Exec

• “A life sciences symposium organized by Dorsey & Whitney will include an unusual guest: Martin Shkreli, the indicted pharmaceutical company CEO who gained notoriety last fall for massively increasing the price of a lifesaving AIDS drug.” (The Recorder)

• In a federal appellate filing, MetLife Inc. defended a judge’s decision to rescind the insurer’s designation as too big to fail, saying the federal regulator that imposed the label relied on “unjustified assumptions.” (Bloomberg/Big Law Business)

• King & Wood Mallesons deferred partner profits in the EUME in Julybecause its recent $18.2 million recapitalization won’t come through until the ...